Gene: IFFO2
Official Full Name: intermediate filament family orphan 2provided by HGNC
Gene Summary: Predicted to be located in intermediate filament. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06978 | IFFO2 Knockout cell line (HeLa) | Human | IFFO2 | 1:3~1:6 | Negative | Online Inquiry |
KO06979 | IFFO2 Knockout cell line (HCT 116) | Human | IFFO2 | 1:2~1:4 | Negative | Online Inquiry |
KO06980 | IFFO2 Knockout cell line (HEK293) | Human | IFFO2 | 1:3~1:6 | Negative | Online Inquiry |
KO06981 | IFFO2 Knockout cell line (A549) | Human | IFFO2 | 1:3~1:4 | Negative | Online Inquiry |
IFFO2 Gene Knockout Cell Lines are a cutting-edge tool designed for researchers focusing on gene function analysis, disease modeling, and therapeutic development. These engineered cell lines are characterized by the complete ablation of the IFFO2 gene, allowing scientists to investigate the biological role of this gene and its associated pathways with unparalleled precision. Utilizing CRISPR-Cas9 technology, these cell lines represent a reliable and robust method for genetic modification, facilitating a clear understanding of gene interactions and cellular responses.
The primary function of IFFO2 Gene Knockout Cell Lines lies in their utility for molecular and biochemical analysis. By knocking out the IFFO2 gene, researchers can employ various assays to explore alterations in cellular behavior, gene expression profiles, and response to pharmacological agents. Notably, the deletion of this gene has been associated with significant insights into metabolic regulation, cellular stress responses, and oncogenic processes.
The scientific importance of these cell lines extends to diverse applications, including drug discovery and validation, toxicological assessment, and the study of genetic diseases. In a clinical setting, they provide a vital resource for developing targeted therapies and personalized medicine approaches, as they mimic disease states and facilitate the evaluation of therapeutic efficacy.
Compared to traditional cell lines, IFFO2 Gene Knockout Cell Lines offer distinct advantages, including enhanced specificity in gene targeting, reduced off-target effects, and streamlined experimentation. This precision not only fosters more reliable scientific outcomes but also accelerates the path from bench to bedside. Furthermore, the availability of pre-validated lines also saves researchers time and resources, enabling them to focus on innovation and discovery.
For researchers and clinicians alike, the value of IFFO2 Gene Knockout Cell Lines is evident. They represent a state-of-the-art solution for dissecting the complexities of gene function and cellular processes. By selecting our product, users gain access to not only a reliable research tool but also the expertise of our company, which is committed to advancing biological research through high-quality, validated biological products tailored to the demands of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.